Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $111.19 million. The enterprise value is $47.95 million.
| Market Cap | 111.19M |
| Enterprise Value | 47.95M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 76.16 million shares outstanding. The number of shares has increased by 8.13% in one year.
| Current Share Class | 76.16M |
| Shares Outstanding | 76.16M |
| Shares Change (YoY) | +8.13% |
| Shares Change (QoQ) | +2.67% |
| Owned by Insiders (%) | 5.58% |
| Owned by Institutions (%) | 62.35% |
| Float | 59.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| Forward PS | 0.54 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | 4.32 |
| P/OCF Ratio | 4.15 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.86 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.70 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 228.30 |
| Debt / FCF | 0.61 |
| Interest Coverage | -1.62 |
Financial Efficiency
Return on equity (ROE) is -84.64% and return on invested capital (ROIC) is -6.35%.
| Return on Equity (ROE) | -84.64% |
| Return on Assets (ROA) | -5.13% |
| Return on Invested Capital (ROIC) | -6.35% |
| Return on Capital Employed (ROCE) | -21.23% |
| Weighted Average Cost of Capital (WACC) | 23.97% |
| Revenue Per Employee | $226,838 |
| Profits Per Employee | -$168,410 |
| Employee Count | 1,200 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $715,000 in taxes.
| Income Tax | 715,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.13% in the last 52 weeks. The beta is 1.51, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -52.13% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 38.22 |
| Average Volume (20 Days) | 355,694 |
Short Selling Information
The latest short interest is 2.07 million, so 2.72% of the outstanding shares have been sold short.
| Short Interest | 2.07M |
| Short Previous Month | 2.21M |
| Short % of Shares Out | 2.72% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 4.59 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $272.21 million and -$202.09 million in losses. Loss per share was -$2.76.
| Revenue | 272.21M |
| Gross Profit | 134.76M |
| Operating Income | -33.81M |
| Pretax Income | -201.38M |
| Net Income | -202.09M |
| EBITDA | -605,000 |
| EBIT | -33.81M |
| Loss Per Share | -$2.76 |
Balance Sheet
The company has $78.99 million in cash and $15.75 million in debt, with a net cash position of $63.24 million or $0.83 per share.
| Cash & Cash Equivalents | 78.99M |
| Total Debt | 15.75M |
| Net Cash | 63.24M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 145.59M |
| Book Value Per Share | 1.91 |
| Working Capital | 54.82M |
Cash Flow
In the last 12 months, operating cash flow was $26.82 million and capital expenditures -$1.11 million, giving a free cash flow of $25.71 million.
| Operating Cash Flow | 26.82M |
| Capital Expenditures | -1.11M |
| Depreciation & Amortization | 33.20M |
| Net Borrowing | -164.37M |
| Free Cash Flow | 25.71M |
| FCF Per Share | $0.34 |
Margins
Gross margin is 49.51%, with operating and profit margins of -12.42% and -74.24%.
| Gross Margin | 49.51% |
| Operating Margin | -12.42% |
| Pretax Margin | -73.98% |
| Profit Margin | -74.24% |
| EBITDA Margin | -0.22% |
| EBIT Margin | -12.42% |
| FCF Margin | 9.45% |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.13% |
| Shareholder Yield | n/a |
| Earnings Yield | -188.98% |
| FCF Yield | 23.12% |
Analyst Forecast
The average price target for Health Catalyst is $1.77, which is 21.03% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.77 |
| Price Target Difference | 21.03% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -9.87% |
| EPS Growth Forecast (3Y) | -10.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -6.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.81 |
| Piotroski F-Score | 4 |